CLINICAL_TRIALS
research
· 2025-03-14
Clinical Trial Update: Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate. [Phase 3]
Summary
Phase 3 clinical trial comparing oral bisoprolol to IV diltiazem for rate control in atrial fibrillation or atrial flutter with rapid ventricular response; curr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oman Medical Speciality Board | Conditions: Atrial Fibrillation With Rapid Ventricular Response, Atrial Flutter With Rapid Ventricular Response | Phase 3 | Status: NOT_YET_RECRUITING